Mesalamine Capsule, Extended Release
NDC 46708-724
Product Information
Mesalamine is a ANDA-approved product labeled by Alembic Pharmaceuticals Limited. This medication is used to treat a certain bowel disease (ulcerative colitis). It is supplied as a blue capsule, extended release for oral administration. This product entry covers the primary NDC 46708-724 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
BLUE (C48333 - OPAQUE LIGHT BLUE BODY)
A;255
Code Structure Chart
Product Details
What is NDC 46708-724?
What are the uses of this product?
What are Active Ingredients of this product?
- MESALAMINE .375 g/1 - An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- MESALAMINE (UNII: 4Q81I59GXC)
- MESALAMINE (UNII: 4Q81I59GXC) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW) (UNII: P2OM2Q86BI)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) (UNII: 74G4R6TH13)
- TALC (UNII: 7SEV7J4R1U)
- TRIETHYL CITRATE (UNII: 8Z96QXD6UM)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST) (UNII: G4U024CQK6)
- FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
- FD&C RED NO. 40 (UNII: WZB9127XOA)
- GELATIN, UNSPECIFIED (UNII: 2G86QN327L)
- SHELLAC (UNII: 46N107B71O)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 825130 - mesalamine 0.375 GM 24HR Extended Release Oral Capsule
- RxCUI: 825130 - 24 HR mesalamine 375 MG Extended Release Oral Capsule
- RxCUI: 825130 - mesalamine 375 MG 24 HR Extended Release Oral Capsule
- RxCUI: 825130 - mesalazine 375 MG 24 HR Extended Release Oral Capsule
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.
Patient Education
Mesalamine
Mesalamine is used to treat ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum) and also to maintain improvement of ulcerative colitis symptoms. Mesalamine is in a class of medications called anti-inflammatory agents. It works by stopping the body from producing a certain substance that may cause inflammation.
[Learn More]
* Please review the full disclaimer at the bottom of this page.